Starling Oncology Institute Inc Com (STLN:NASDAQ) closed at $6.71 on October 23, 2026, down 2.89% on the day. The stock trades 5.9% below its 52-week high of $7.13 and 189.2% above its 52-week low of $2.32. Over the past year, it gained 152.3%. Starling Oncology Institute Inc Com is part of the Health Care sector.
In 173 trading sessions since February 18, 2026, STLN closed higher on 88 days (51%). Its best day was August 7, 2026 (+28.46%) and its worst was July 15, 2026 (-9.87%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.
Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, TOI is changing oncology for the better.
Find more stocks like STLN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.